ʻO kaʻike kiko'ī no ka tb maʻi a me mdr-tb

ʻO Tucberculosis (TB),ʻoiai ke paleʻia a paleʻole, e waiho ana i kahi hoʻoweliweli olakino olakino. Ua manaʻoʻia he 10.6 miliona mau kānaka i hāʻule me ka tb i 2022, e hopena ana i ka makeʻana o ka makahiki 2025 Eia hou,ʻo Anti-Tb i ke kū'ēʻana, hoʻokahi mdr-tb (ka paleʻana iā Rif & Inh)

ʻO ka maikaʻi a me ka pololei tb a me ke kiʻiʻana i keʻano o ka maʻi lapaʻau anti-tb

ʻO kā mākou Pōkuhi

Marco & Micro-hōʻike3-IN-1 TB Eʻike i ka nānāʻana no TB Health / RIF & NIH Ke kū'ēʻanaʻIkeʻia ka nānāʻana i nā kitlelo i ka maʻi maʻi o TB a me RIF / INH ma kahi o kaʻikeʻana i kaʻenehana curve curve.

3-IN-1 TB / MDR-TB E nānā i ka hopena o TB a me ke kī mua i ka hana a me ke kumu kūʻai.

ʻO ka Myscoctersium Tuacpelesis nuklecle acid a me Rifamhickin

Ke hōʻike nei i ka ho'āʻoʻana i ka Triple Triple Triple

ʻO ka hopena Rapid:Loaʻa ma 2-2.5 mau hola me ka hopena o ka hoʻopiliʻana i ka weheweheʻana i ka hōʻemiʻana i ka hoʻomaʻamaʻa loea no ka hana;

Hōʻike Hōʻike Manaʻo:ʻO Sputum, lj medium, mgit medium, bronchial Lavage;

Kūlā kiʻekiʻe:110 BACTERIA / ML no TB, 150 Bucteria / ML no ka pale kaua, he mau mea nānā i ka nui o nā pale i loko.

Nā Kūlana Nui:Tb-he6110; Rif-resistist-rpob (507 ~ 533); Inh-resististance-inha, ahpc, katg 315;

Ka Manaʻo Kūlana:Ka mana kūloko no keʻano o keʻano o ka hōʻikeʻana i ka hopena o ka ho'ēmiʻana e hōʻemi ai i nā hana maʻamau;

Laulā ākeaY: kūlike me ka hapa nui o nā'ōnaehana PCR no ka nui o ka ACCUBity ākea (SLAN-96P, BHID CFX96);

ʻO ka mea e hoʻoponopono pono ai i nā kulekele:Ke hana nei i nā alakaʻi no ka hoʻokeleʻana o ka hoʻokeleʻana o ka lāʻau lapaʻau-resistunistis


Post Times: Sep-19-2024